Literature DB >> 10231007

Immunity to heat shock proteins and pregnancy outcome.

S S Witkin1.   

Abstract

Heat shock proteins are among the first proteins produced by the zygote after fertilization. In addition, the maternal decidua also expresses heat shock proteins during the early stages of pregnancy. Autoimmunity to heat shock proteins is not typically evident in healthy women of reproductive age. However, a chronic microbial infection, such as an asymptomatic Chlamydia trachomatis upper genital tract infection, results in prolonged exposure of the immune system to the microbial 60 kDa heat shock protein (hsp60). This may result in immunity to conserved hsp60 epitopes and subsequent autoimmunity to self hsp60. Women undergoing in vitro fertilization (IVF) who never realized they had a chlamydial infection but who were positive for cervical antichlamydial immunoglobulin A (IgA) antibodies had a much lower pregnancy rate than did women who were negative for these antibodies. Furthermore, cervical IgA antibodies to the chlamydial hsp60, as well as to a synthetic peptide corresponding to an hsp60 epitope present in both the chlamydial and human hsp60, also correlated with IVF failure. In vitro incubation of newly fertilized human embryos in medium containing maternal serum was shown to be deleterious to embryo development if the sera was positive for antibodies reactive with human hsp60. In another study, the ability of human hsp60 to elicit a lymphocyte proliferative response (cell-mediated immunity) correlated with a history of spontaneous early stage pregnancy loss. Thus, autoimmunity to hsp60 might increase susceptibility to early stage pregnancy loss.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10231007      PMCID: PMC1784708          DOI: 10.1155/S1064744999000083

Source DB:  PubMed          Journal:  Infect Dis Obstet Gynecol        ISSN: 1064-7449


  16 in total

1.  Humoral immune response to membrane components of Chlamydia trachomatis and expression of human 60 kDa heat shock protein in follicular fluid of in-vitro fertilization patients.

Authors:  A Neuer; K N Lam; F W Tiller; L Kiesel; S S Witkin
Journal:  Hum Reprod       Date:  1997-05       Impact factor: 6.918

2.  Humoral immune response to conserved epitopes of Chlamydia trachomatis and human 60-kDa heat-shock protein in women with pelvic inflammatory disease.

Authors:  M Domeika; K Domeika; J Paavonen; P A Mårdh; S S Witkin
Journal:  J Infect Dis       Date:  1998-03       Impact factor: 5.226

3.  Atypical pelvic inflammatory disease: can we identify clinical predictors?

Authors:  W Cates; M R Joesoef; M B Goldman
Journal:  Am J Obstet Gynecol       Date:  1993-08       Impact factor: 8.661

4.  Unsuspected Chlamydia trachomatis infection and in vitro fertilization outcome.

Authors:  S S Witkin; K M Sultan; G S Neal; J Jeremias; J A Grifo; Z Rosenwaks
Journal:  Am J Obstet Gynecol       Date:  1994-11       Impact factor: 8.661

5.  Serological responses of patients with ectopic pregnancy to epitopes of the Chlamydia trachomatis 60 kDa heat shock protein.

Authors:  I Sziller; S S Witkin; M Ziegert; Z Csapó; A Ujházy; Z Papp
Journal:  Hum Reprod       Date:  1998-04       Impact factor: 6.918

6.  Monoclonal antibodies to mammalian heat shock proteins impair mouse embryo development in vitro.

Authors:  A Neuer; C Mele; H C Liu; Z Rosenwaks; S S Witkin
Journal:  Hum Reprod       Date:  1998-04       Impact factor: 6.918

7.  Morphologic and antigenic characterization of interferon gamma-mediated persistent Chlamydia trachomatis infection in vitro.

Authors:  W L Beatty; G I Byrne; R P Morrison
Journal:  Proc Natl Acad Sci U S A       Date:  1993-05-01       Impact factor: 11.205

8.  Circulating antibodies to a conserved epitope of the Chlamydia trachomatis 60 kDa heat shock protein (hsp60) in infertile couples and its relationship to antibodies to C.trachomatis surface antigens and the Escherichia coli and human HSP60.

Authors:  S S Witkin; M Askienazy-Elbhar; J Henry-Suchet; J Belaisch-Allart; J Tort-Grumbach; K Sarjdine
Journal:  Hum Reprod       Date:  1998-05       Impact factor: 6.918

9.  Spontaneous high expression of heat-shock proteins in mouse embryonal carcinoma cells and ectoderm from day 8 mouse embryo.

Authors:  O Bensaude; M Morange
Journal:  EMBO J       Date:  1983       Impact factor: 11.598

10.  Antibodies to heat-shock protein 27 are associated with improved survival in patients with breast cancer.

Authors:  S E Conroy; P D Sasieni; V Amin; D Y Wang; P Smith; I S Fentiman; D S Latchman
Journal:  Br J Cancer       Date:  1998-06       Impact factor: 7.640

View more
  6 in total

Review 1.  Chlamydia trachomatis: the Persistent Pathogen.

Authors:  Steven S Witkin; Evelyn Minis; Aikaterini Athanasiou; Julie Leizer; Iara M Linhares
Journal:  Clin Vaccine Immunol       Date:  2017-10-05

2.  Maternal Antibodies to Chlamydia trachomatis and Risk of Gastroschisis.

Authors:  Samantha E Parker; Martha M Werler; Mika Gissler; Heljä-Marja Surcel
Journal:  Birth Defects Res       Date:  2017-02-24       Impact factor: 2.344

Review 3.  Chaperonins in disease: mechanisms, models, and treatments.

Authors:  J C Ranford; B Henderson
Journal:  Mol Pathol       Date:  2002-08

4.  Silencing of chaperonin 21, that was differentially expressed in inflorescence of seedless and seeded grapes, promoted seed abortion in tobacco and tomato fruits.

Authors:  Uri Hanania; Margarita Velcheva; Etti Or; Moshe Flaishman; Nachman Sahar; Avihai Perl
Journal:  Transgenic Res       Date:  2006-11-14       Impact factor: 3.145

Review 5.  Antichlamydial antibodies, human fertility, and pregnancy wastage.

Authors:  Amanda J Stephens; Mira Aubuchon; Danny J Schust
Journal:  Infect Dis Obstet Gynecol       Date:  2011-09-22

Review 6.  Chlamydia trachomatis infection and anti-Hsp60 immunity: the two sides of the coin.

Authors:  Francesco Cappello; Everly Conway de Macario; Valentina Di Felice; Giovanni Zummo; Alberto J L Macario
Journal:  PLoS Pathog       Date:  2009-08-28       Impact factor: 6.823

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.